BCM
LLY icon

BluePointe Capital Management’s Eli Lilly LLY Stock Holding History

BluePointe Capital Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$545K Buy
660
+275
+71% +$229K 0.21% 72
2024
Q4 		$297K Buy
+385
New +$319K 0.17% 80

Other funds holding LLY

PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

BluePointe Capital Management's LLY Position: Q1 2025 in Review

BluePointe Capital Management increased its Eli Lilly (LLY) stake by 71% in Q1 2025, buying an estimated $229K and bringing the position to 660 shares worth $545K. The position accounts for 0.21% of the portfolio, ranked #72.

BluePointe Capital Management first reported a position in LLY in Q4 2024 and has held it in 2 quarters since. 3,927 funds tracked by Wall St. Rank hold LLY as of Q1 2025.

  • BluePointe Capital Management held 660 shares of Eli Lilly worth $545K as of Q1 2025.
  • BluePointe Capital Management bought 275 Eli Lilly shares in Q1 2025, an estimated $229K.
  • Eli Lilly made up 0.21% of BluePointe Capital Management's portfolio in Q1 2025, its #72 holding.
  • BluePointe Capital Management first reported a position in Eli Lilly in Q4 2024 and has held it in 2 quarters since.
  • 3,927 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2025.

Based on BluePointe Capital Management's 13F filing for Q1 2025, filed 2 May 2025.